Healthier World with Quest Diagnostics
Healthier World with Quest Diagnostics aims to prompt action from insight as we keep you up to date on current clinical and diagnostic topics in cardiovascular, metabolic, endocrine, and wellness medicine.
Episodes

Tuesday Sep 24, 2024
Instant Insights: Lipoprotein (a) (6 min)
Tuesday Sep 24, 2024
Tuesday Sep 24, 2024
Despite advances in understanding the pathogenesis and prevention of atherosclerotic cardiovascular disease, coronary heart disease remains the leading cause of death in the United States. Lipoprotein (a), or Lp(a), is a particularly atherogenic type of lipoprotein, where excess levels significantly influence cardiovascular risk.
This episode will:
Review the significant cardiovascular implications of Lp(a) excess
Describe Lp(a) structure
Discuss how Lp(a) is measured
Review the treatment landscape for Lp(a)
To learn more, please review the additional resources below for information on our cardiovascular, metabolic, endocrine, and wellness offerings, as well as educational resources and insights from our team of experts. At Quest Diagnostics, we are committed to providing you with results and insights to support your clinical decisions.
Date: 9/10/24
Speaker(s): Maeson Latsko, PhD
Contributor(s): Maeson Latsko, PhD, Trisha Winchester, PhD
Additional Resources:
Ordering information: Lipoprotein (a) | Test Detail | Quest Diagnostics
Lipoprotein(a) | Test Summary | Quest Diagnostics
Quest Diagnostics Clinical Education Center [Link]
References:
Wilson DP, Jacobson TA, Jones PH, et al. Use of Lipoprotein(A) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. J Clin Lipidol. 2019;13(3):374-392. doi:10.1016/j.jacl.2019.04.010
Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024;18(3):e308-e319. doi:10.1016/j.jacl.2024.03.001

Wednesday Jun 05, 2024
Laboratory assessment in the diagnosis of male hypogonadism (16 min)
Wednesday Jun 05, 2024
Wednesday Jun 05, 2024
Hypogonadism is a common condition in the male population, impacting approximately 35% of men over 45 years of age. Today’s episode is with Quest Diagnostics experts Dr Sanjay Dixit, MD, medical director, and Maeson Latsko, PhD, clinical specialist.
This episode will:
Review the clinical and biochemical changes seen in male patients with hypogonadism (1:20)
Discuss the guideline-recommended methodologies for testosterone analysis (3:24)
Learn how to delineate between primary and secondary hypogonadism (7:38)
To learn more, please view the additional resources below for information on our cardiovascular, metabolic, endocrine, and wellness offerings as well as educational resources and insights from our team of experts. At Quest Diagnostics, we are committed to providing you with results and insights to support your clinical decisions.
Date: May 3, 2024
Contributor(s): Dr. Sanjay Dixit, MD, Maeson Latsko, PhD
Additional Resources:
Quest Diagnostics Clinical Education Center
Quest Diagnostics Hypogonadism FAQs
Clinical Focus: Hypogonadism and Low Testosterone in Men
Adult Male Hypogonadism Diagnostic Algorithm
References See Quest Diagnostics Clinical Education Center

Wednesday Jun 05, 2024
Laboratory testing for the diagnosis and management of thyroid disorders (21 min)
Wednesday Jun 05, 2024
Wednesday Jun 05, 2024
An estimated 20 million Americans have some form of thyroid disease, and up to 60% of them are unaware of their condition. Today’s episode is with Quest Diagnostics experts Dr Sanjay Dixit, MD, medical director, and Sarah Walsh, PA-C, CLS, clinical specialist.
This episode will:
Identify common signs and symptoms of thyroid dysfunction
Identify lab recommendations to support the diagnosis of hypo- and hyperthyroidism
Discuss the association between cardiometabolic conditions and thyroid dysfunction
To learn more, please review the additional resources below for information on our cardiovascular, metabolic, endocrine and wellness offerings, as well as educational resources and insights from our team of experts. At Quest Diagnostics, we are committed to providing you with results and insights to support your clinical decisions.
Date: 4/18/2024
Contributor(s): Dr. Sanjay Dixit, MD, Sarah Walsh, PA-C, CLS
Additional Resources:
Quest Diagnostics Clinical Education Center
Quest Diagnostics Thyroid Disorders
Clinical Focus: Thyroid Dysfunction in Nonpregnant Adults
Testing Algorithm for Thyroid Dysfunction in Nonpregnant Adults
References See Quest Diagnostics Clinical Education Center

Wednesday Jun 05, 2024
Laboratory assessment in PCOS diagnosis and management (19 min)
Wednesday Jun 05, 2024
Wednesday Jun 05, 2024
Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine diagnoses for reproductive-aged women and carries lifelong cardiometabolic risk. Today’s episode is with Quest Diagnostics experts Dr Sanjay Dixit, MD, medical director, and Sarah Walsh, PA-C, CLS, clinical specialist.
This episode will:
Review the diagnostic criteria for PCOS (2:00)
Identify lab recommendations to support the diagnosis of PCOS (6:00)
Discuss associated cardiometabolic conditions and how to screen and monitor for these conditions (14:45)
To learn more, please review the additional resources below for information on our cardiovascular, metabolic, endocrine, and wellness offerings as well as educational resources and insights from our team of experts. At Quest Diagnostics, we are committed to providing you with results and insights to support your clinical decisions.
Date recorded: 4/9/2024
Contributor(s): Dr. Sanjay Dixit, MD, Sarah Walsh, PA-C, CLS
Additional Resources:
Quest Diagnostics Polycystic ovary syndrome
Clinical Focus: Polycystic Ovary Syndrome
Polycystic Ovary Syndrome (PCOS) Diagnostic Algorithm
Laboratory Testing in the Differential Diagnosis of PCOS and NCCAH
References See Quest Diagnostics Clinical Education Center